Page last updated: 2024-10-24

chlorambucil and Dystonia

chlorambucil has been researched along with Dystonia in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Zanducke, M1
Dehaene, I1

Other Studies

1 other study available for chlorambucil and Dystonia

ArticleYear
A "cortico-basal degeneration"-like syndrome as first sign of progressive multifocal leukoencephalopathy.
    Acta neurologica Belgica, 2000, Volume: 100, Issue:4

    Topics: Aged; Antineoplastic Agents, Alkylating; Apraxias; Chlorambucil; Cognition Disorders; Combined Modal

2000